Kittner, J. M.; von Bialy, L.; Wiltink, J. et al.
Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohortINFECTION. Bd. 43. H. 3. 2015 S. 299-305
Nguyen-Tat, M.; Goetz, E.; Scholz-Kreisel, P. et al.
Liver Cirrhosis and hepatorenal Syndrome: The Response to Terlipressin and Albumin is associated with better SurvivalDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 140. H. 2. 2015 S. E21-E26
Dopheide, Joern F.; Knopf, Pascal; Zeller, Geraldine C. et al.
Low IL-10/TNF alpha Ratio in Patients with Coronary Artery Disease and Reduced Left Ventricular Ejection Fraction with a Poor Prognosis After 10 YearsINFLAMMATION. Bd. 38. H. 2. 2015 S. 911-922
Fichter, Michael; Dedters, Marvin; Pietrzak-Nguyen, Anette et al.
Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosageVACCINE. Bd. 33. H. 7. 2015 S. 838-846
Anlauf, M.; Neumann, M.; Bomberg, S. et al.
Neuroendocrine neoplasms of the breastPATHOLOGE. Bd. 36. H. 3. 2015 S. 261-270
Darstein, F.; Koenig, C.; Hoppe-Lotichius, M. et al.
New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factorEUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 26. H. 6. 2015 S. 439-444
Schattenberg, Joern M.
Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional AspectsERNAHRUNGS UMSCHAU. Bd. 62. H. 2. 2015 S. M92-M100
Wagner, Anna Dorothea; Moehler, Markus; Grothe, Wilfried et al.
Novel chemotherapy combinations for metastatic gastric adenocarcinoma (mAGC): An updated meta-analysisJOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 3. 2015
Nguyen-Tat, M.; Schattenberg, J. M.
Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 53. H. 7. 2015 S. 724-725
Vogel, Arndt; Kasper, Stefan; Weichert, Wilko et al.
Panitumumab in combination with gemcitabine/cisplatin (GemCis) for patients with advanced kRAS WT biliary tract cancer: A randomized phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015